Australian Centre for Blood Diseases home
Australian Centre for Blood Diseases home
The Australian Centre for Blood Diseases (ACBD) is a recognised leader in blood disease research and education. Working in a state-of-the-art facility, our experts are setting new standards in diagnosing and treating blood conditions.
We're part of the Central Clinical School.
About us
We're tackling the biggest challenges of blood diseases, from clotting to cancers such as lymphoma, leukemia and myeloma.

Research
Our focus is on turning new discoveries into better patient outcomes. We're particularly interested in blood cancers, thrombosis and bleeding disorders.

Education
From the fundamentals of blood disease to the most complex issues, we offer a range of undergraduate and postgraduate study options. See Prof Harshal Nandurkar presenting in the 2020 Honours information night.

Supervisor Connect
Browse our Research Projects booklet (2.18 MB Pdf), for projects currently on offer. See our 2020 info night video. Start your research journey with Monash University’s largest research Faculty.
Australian Centre for Blood Diseases news
-
Drug clinical trial improves survival for AML patients 29 December, 2020
-
Congratulations to our recent PhD completions in translational medicine! 16 November, 2020
-
A first-in-class antibody designed to prevent clotting 22 September, 2020

Clinical services
Through our affiliation with Alfred Health's Haematology Department, we're involved in many clinical trials and research projects.

Donate blood
Have you ever thought of donating blood for research? Our vital blood clotting work relies on donations, and you can help.

Professor Harshal Nandurkar
Professor Harshal Nandurkar describes Monash Alfred Research Alliance Australian Centre for Blood Diseases research.

Spotlight on research
Dr Crispin Szydzik in Dr Warwick Nesbitt's group has won an award for best PhD thesis in engineering from RMIT for his lab-on-a-chip work. See story.
@ACBDresearch
RT @BenJMarsland: Well, we just followed the data and ended up finding microbial metabolism of L-tyrosine reduces lung inflammation! @Tomas…
@ACBDresearch
RT @AlfredHealth: It’s been exactly one year since the first case of COVID-19 was detected in Australia. Since that day our pathology team…
@ACBDresearch
RT @peripatetical: The TGA has announced provisional approval of the Pfizer-BioNTech COVID vaccine. Supplies can now be shipped to Australi…
@ACBDresearch
RT @EricTopol: Excellent new primer on B cell memory to counter covid-19, with sterilization vs protective immunity , rationale for 2 doses…